Greenville Health System Cancer Institute-Butternut — Greenville, South Carolina

Greenville Health System Cancer Institute-Butternut is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Greenville Health System Cancer Institute-Butternut has participated in 57 clinical trials with 9 currently active.

Therapeutic areas: Plasma Cell Myeloma, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System Cancer Institute-Butternut?

Greenville Health System Cancer Institute-Butternut has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System Cancer Institute-Butternut conducted?

Greenville Health System Cancer Institute-Butternut has 57 clinical trials on record, with 9 currently active. Their work covers Plasma Cell Myeloma, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer.

Is Greenville Health System Cancer Institute-Butternut accredited by Crixeo Health?

Yes — Greenville Health System Cancer Institute-Butternut holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Greenville Health System Cancer Institute-Butternut?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.